199 related articles for article (PubMed ID: 31236124)
1. Efficacy and Safety of Xiao Ai Ping Injection Combined with Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Wu K; Zhu Z; He Y; Huang L; Yan X; Wang D
Evid Based Complement Alternat Med; 2019; 2019():3821053. PubMed ID: 31236124
[TBL] [Abstract][Full Text] [Related]
2. Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Feng F; Huang J; Wang Z; Zhang J; Han D; Wu Q; He H; Zhou X
BMC Complement Med Ther; 2020 Jan; 20(1):3. PubMed ID: 32020869
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal medicine combined with oxaliplatin-based chemotherapy for advanced gastric cancer: A systematic review and meta-analysis of contributions of specific medicinal materials to tumor response.
Tan Y; Wang H; Xu B; Zhang X; Zhu G; Ge Y; Lu T; Gao R; Li J
Front Pharmacol; 2022; 13():977708. PubMed ID: 36091754
[No Abstract] [Full Text] [Related]
4. Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Li A; Liu S; Zhang H; Lin M; Guo L; Yuan C; Li Z; Xu J; Wang T
Medicine (Baltimore); 2023 Oct; 102(40):e35483. PubMed ID: 37800773
[TBL] [Abstract][Full Text] [Related]
5. Oral and injectable Marsdenia tenacissima extract (MTE) as adjuvant therapy to chemotherapy for gastric cancer: a systematic review.
Zhou X; Liu M; Ren Q; Zhu W; Wang Y; Chen H; Chen J
BMC Complement Altern Med; 2019 Dec; 19(1):366. PubMed ID: 31830977
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer: A systematic review and meta-analysis.
Xu B; Wang X; Wang H; Cao L; Ge Y; Yuan B; Gao R; Li J
Front Cell Infect Microbiol; 2022; 12():875225. PubMed ID: 35992176
[TBL] [Abstract][Full Text] [Related]
7. Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines.
Song Q; Zhang J; Wu Q; Li G; Leung EL
Medicine (Baltimore); 2020 Apr; 99(17):e19480. PubMed ID: 32332600
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficacy and safety of capecitabine or tegafur, gimeracil and oteracil potassium capsules combined with oxaliplatin chemotherapy regimens in the treatment of advanced gastric cancer].
Wan Y; Hui H; Wang X; Wu J; Sun S
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):28-34. PubMed ID: 26796803
[TBL] [Abstract][Full Text] [Related]
10. S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis.
Bian NN; Wang YH; Min GT
Int J Surg; 2019 Feb; 62():34-43. PubMed ID: 30641155
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of Chinese herbal injections in combination with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of 140 randomized controlled trials.
Cao K; Hu S; Wang D; Qiao C; Wang Z; Wang J; Hou W
Front Oncol; 2024; 14():1307836. PubMed ID: 38371619
[TBL] [Abstract][Full Text] [Related]
12. Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study.
Jiang Z; Sun Y; Zhang W; Cui C; Yang L; Zhou A
Asia Pac J Clin Oncol; 2020 Jun; 16(3):180-186. PubMed ID: 32077628
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Sun L; Ma JT; Zhang SL; Zou HW; Han CB
Med Oncol; 2015 Feb; 32(2):473. PubMed ID: 25603953
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis.
Qiao C; Hu S; Wang D; Cao K; Wang Z; Wang X; Ma X; Li Z; Hou W
Front Oncol; 2023; 13():1198768. PubMed ID: 37731634
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy of Ginsenoside Rg3 Combined with First-line Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer in China: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Peng Z; Wu WW; Yi P
Front Pharmacol; 2020; 11():630825. PubMed ID: 33815097
[No Abstract] [Full Text] [Related]
16. Clinical Effectiveness and Safety of Chinese Herbal Medicine Compound Kushen Injection as an Add-On Treatment for Breast Cancer: A Systematic Review and Meta-Analysis.
Lai BY; Chu AJ; Yu BW; Jia LY; Fan YY; Liu JP; Pei XH
Evid Based Complement Alternat Med; 2022; 2022():8118408. PubMed ID: 35047051
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials.
Xu HB; Huang F; Su R; Shen FM; Lv QZ
Eur J Clin Pharmacol; 2015 May; 71(5):589-601. PubMed ID: 25795200
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of elemene combined with chemotherapy in advanced gastric cancer: A Meta-analysis.
Liu Y; Chen L; Zhang R; Chen B; Xiang Y; Zhang M; Huang X; Zhang W; Chen X; Pan T; Yan L; Jin T; Liu S; Feng J; Duan T; Xie T; Lin S; Sui X
Medicine (Baltimore); 2020 Mar; 99(11):e19481. PubMed ID: 32176081
[TBL] [Abstract][Full Text] [Related]
19. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of
Cheng M; Hu J; Zhao Y; Jiang J; Qi R; Chen S; Li Y; Zheng H; Liu R; Guo Q; Zhang X; Qin Y; Hua B
Front Oncol; 2021; 11():632168. PubMed ID: 34422628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
